IRD · Opus Genetics, Inc. · Documents

$4.27 +0.34 (+8.65%) At close · Nov 4

Russell 2000 member Rebalance outlook locked

Market Cap

$326.96M

83.20M

Volume · Nov 4 1.16M Avg daily vol (3M) 2.48M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021

Jan 6

Current report 8-K

Regulation FD disclosure

2020

Dec 30

Current report 8-K/A Events of Nov 5

Current report

Nov 25

Current report 8-K Events of Nov 19

Entered into a material agreement, Unregistered sale of equity

Nov 17

Current report 8-K Events of Nov 11

Director or officer change, or executive pay

Nov 6

Current report 8-K

Entered into a material agreement, Completed an acquisition or sale of assets, Change to shareholders' rights, Change of auditor, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Code of ethics change or waiver

Nov 3

Current report 8-K Events of Nov 2

Director or officer change, or executive pay, Shareholder vote results, Other events

Oct 29

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Net loss $1.4M

Oct 9

Current report 8-K Events of Oct 8

Other events

Sep 30

Registration statement S-4/A

Registration statement

Sep 16

Registration statement S-4/A

Registration statement

Sep 11

Current report 8-K Events of Sep 10

Entered into a material agreement, Unregistered sale of equity

Sep 2

Current report 8-K Events of Sep 1

Entered into a material agreement, Unregistered sale of equity

Aug 27

Registration statement S-4/A

Registration statement

Aug 14

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Net loss $2.51M

Aug 3

Current report 8-K Events of Jul 31

Entered into a material agreement, Unregistered sale of equity

Jul 6

Registration statement S-4

Registration statement

Jul 1

Current report 8-K Events of Jun 29

Entered into a material agreement, Ended a material agreement

Jun 19

Current report 8-K Events of Jun 17

Entered into a material agreement, Director or officer change, or executive pay, Other events

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $1.15M Net loss $586.77K

Apr 29

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2019

Apr 9

Current report 8-K Events of Apr 7

Ended a material agreement

Mar 16

Current report 8-K Events of Mar 10

Entered into a material agreement

Feb 21

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Revenue $3M Net loss $8.64M

Feb 10

Current report 8-K Events of Feb 8

Other events

Showing 151–174 of 174 documents

Key facts CIK 1228627 CUSIP 67577R102 13F (30d) 23 filings 23 filers Visit website Investor relations